Could skipping a drug speed up hospital discharge after cancer treatment?
NCT ID NCT03317899
Summary
This study tested whether patients with multiple myeloma or non-Hodgkin lymphoma could recover just as quickly after a stem cell transplant without receiving a standard recovery-boosting drug (G-CSF). The main goal was to see if skipping this drug led to a similar time until patients were ready to leave the hospital. Researchers compared recovery times, infection rates, and other health measures between patients who received the drug and those who did not.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMA CELL MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.